Allogene Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Portfolio Pulse from
Allogene Therapeutics, Inc. (Nasdaq: ALLO) will release its Q4 and full year 2024 financial results and provide a business update on March 13, 2025. The announcement will be followed by a webcast and conference call.
March 03, 2025 | 1:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Allogene Therapeutics will report its Q4 and full year 2024 financial results on March 13, 2025. This event could impact ALLO's stock price depending on the financial performance and business updates shared.
The announcement of financial results is a significant event for any publicly traded company as it provides insights into the company's performance. The impact on ALLO's stock price will depend on the financial results and any business updates provided during the webcast and conference call.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100